Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy

Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191. Summary Background Thymus‐and‐activation‐regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental allergy 2011-02, Vol.41 (2), p.186-191
Hauptverfasser: Miyahara, H., Okazaki, N., Nagakura, T., Korematsu, S., Izumi, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 191
container_issue 2
container_start_page 186
container_title Clinical and experimental allergy
container_volume 41
creator Miyahara, H.
Okazaki, N.
Nagakura, T.
Korematsu, S.
Izumi, T.
description Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191. Summary Background Thymus‐and‐activation‐regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical cord blood CCL17 to atopic dermatitis (AD) development have not yet been examined. Objective Seventy paired full‐term and normal vaginal delivery newborns and their mothers were enrolled in this study. Methods To elucidate the pathogenesis and fetomaternal inheritance of AD in infancy, CCL17, IFN‐γ‐inducible protein 10 kDa (IP‐10; CXCL10), soluble HLA‐G (sHLA‐G), IgE and eosinophil counts were examined using sera from 70 paired umbilical cord and maternal blood samples. Results Serum CCL17 (rs=0.340, P
doi_str_mv 10.1111/j.1365-2222.2010.03634.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_862781738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>862781738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5624-b3f179029e2fe6b6334f685f573adafbbe2af51abbe1a986c1e8be3dc8d101523</originalsourceid><addsrcrecordid>eNqNkU2P0zAQhi0EYrsLfwFZQohTunYcJ_aBQxXKgqgALYv2aDnOGFzytXbCtv8eh5YicYGRJY_Gz-sZ-0UIU7KkMS63S8pynqQxlimJVcJyli13D9DidPAQLYjkWVIImZ2h8xC2hBDGpXiMzlJKeMaFWKCv6wZ-6BFqPLWVa5zRDTa9r3EAP7X4ZnVdXpblhhY4ctAEPHionRnx-A1wPZf6oYVuxL3FeuwHZ2LVt3p0owvYdXFZ3Zn9E_TI6ibA0-N-gb68Wd-Ub5PNx6t35WqTGJ6nWVIxSwtJUgmphbzKGctsLrjlBdO1tlUFqbac6phQLUVuKIgKWG1ETQnlKbtALw_3Dr6_myCMqnXBQNPoDvopKJGnhaAFE_8ms_hblEkZyed_kdt-8l18hootJSeRopESB8r4PgQPVg3etdrvFSVqdk1t1WyOms1Rs2vql2tqF6XPjg2mqoX6JPxtUwReHAEdokPWxy914Q_HCha9nWd4deDuXQP7_x5AlevVnEV9ctC7MMLupNf-u8oLVnB1--FK3b6-fv9ZfsoUYz8B03LAyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1529501391</pqid></control><display><type>article</type><title>Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Miyahara, H. ; Okazaki, N. ; Nagakura, T. ; Korematsu, S. ; Izumi, T.</creator><creatorcontrib>Miyahara, H. ; Okazaki, N. ; Nagakura, T. ; Korematsu, S. ; Izumi, T.</creatorcontrib><description><![CDATA[Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191. Summary Background Thymus‐and‐activation‐regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical cord blood CCL17 to atopic dermatitis (AD) development have not yet been examined. Objective Seventy paired full‐term and normal vaginal delivery newborns and their mothers were enrolled in this study. Methods To elucidate the pathogenesis and fetomaternal inheritance of AD in infancy, CCL17, IFN‐γ‐inducible protein 10 kDa (IP‐10; CXCL10), soluble HLA‐G (sHLA‐G), IgE and eosinophil counts were examined using sera from 70 paired umbilical cord and maternal blood samples. Results Serum CCL17 (rs=0.340, P<0.001) and sHLA‐G (rs=0.600, P<0.001) levels showed high correlations between umbilical cord and maternal blood. Umbilical cord serum levels of CCL17 from neonates destined to develop AD in infancy were higher than in those from neonates who showed no signs of AD during infancy (median 1586.9 vs. 819.6 pg/mL, P<0.001). Serum levels of CCL17 were higher in mothers with AD than in those without AD (median 909.6 vs. 214.1 pg/mL, P<0.001). High umbilical cord serum levels of CCL17 were associated with infantile AD development even in 62 neonates born to mothers without AD (median 1514.4 vs. 740.6 pg/mL, P<0.001) and 38 neonates born to mothers with no allergies (median 1624.2 vs. 740.6 pg/mL, P<0.001). The summary estimates for umbilical cord serum CCL17 in the diagnosis of infantile AD were: sensitivity 85.7% (95% confidence interval: 72.8–98.7), specificity 73.8% (60.5–87.1), positive predictive value 68.6% (53.2–84.0) and negative predictive value 88.6% (78.0–99.1). Conclusion and Clinical Relevance These findings suggest that the umbilical cord blood CCL17 may be involved in the pathogenesis of infantile AD and in fetomaternal inheritance. Serum levels of CCL17 from umbilical cord blood may be a predictive marker for AD in infancy.]]></description><identifier>ISSN: 0954-7894</identifier><identifier>EISSN: 1365-2222</identifier><identifier>DOI: 10.1111/j.1365-2222.2010.03634.x</identifier><identifier>PMID: 21054588</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Age of Onset ; Allergic diseases ; Atopic dermatitis ; Biological and medical sciences ; Biomarkers - blood ; Case-Control Studies ; CCL17 ; CCL17 protein ; Chemokine CCL17 - blood ; chemokine TARC ; Child, Preschool ; Confidence intervals ; CXCL10 protein ; Dermatitis, Atopic - blood ; Dermatitis, Atopic - congenital ; Female ; Fetal Blood - chemistry ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; gamma -Interferon ; Heredity ; Histocompatibility antigen HLA ; Humans ; Hypersensitivity ; Immunoglobulin E ; Immunopathology ; Infant ; Infant, Newborn ; IP-10 protein ; Leukocytes (eosinophilic) ; Male ; Medical sciences ; Neonates ; Pathogenesis ; Predictive Value of Tests ; Pregnancy ; Prognosis ; Reproducibility of Results ; Serum levels ; Skin allergic diseases. Stinging insect allergies ; Stem cells ; TARC ; Umbilical cord ; umbilical cord blood ; Vagina</subject><ispartof>Clinical and experimental allergy, 2011-02, Vol.41 (2), p.186-191</ispartof><rights>2010 Blackwell Publishing Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2010 Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5624-b3f179029e2fe6b6334f685f573adafbbe2af51abbe1a986c1e8be3dc8d101523</citedby><cites>FETCH-LOGICAL-c5624-b3f179029e2fe6b6334f685f573adafbbe2af51abbe1a986c1e8be3dc8d101523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2222.2010.03634.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2222.2010.03634.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23730031$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21054588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyahara, H.</creatorcontrib><creatorcontrib>Okazaki, N.</creatorcontrib><creatorcontrib>Nagakura, T.</creatorcontrib><creatorcontrib>Korematsu, S.</creatorcontrib><creatorcontrib>Izumi, T.</creatorcontrib><title>Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy</title><title>Clinical and experimental allergy</title><addtitle>Clin Exp Allergy</addtitle><description><![CDATA[Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191. Summary Background Thymus‐and‐activation‐regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical cord blood CCL17 to atopic dermatitis (AD) development have not yet been examined. Objective Seventy paired full‐term and normal vaginal delivery newborns and their mothers were enrolled in this study. Methods To elucidate the pathogenesis and fetomaternal inheritance of AD in infancy, CCL17, IFN‐γ‐inducible protein 10 kDa (IP‐10; CXCL10), soluble HLA‐G (sHLA‐G), IgE and eosinophil counts were examined using sera from 70 paired umbilical cord and maternal blood samples. Results Serum CCL17 (rs=0.340, P<0.001) and sHLA‐G (rs=0.600, P<0.001) levels showed high correlations between umbilical cord and maternal blood. Umbilical cord serum levels of CCL17 from neonates destined to develop AD in infancy were higher than in those from neonates who showed no signs of AD during infancy (median 1586.9 vs. 819.6 pg/mL, P<0.001). Serum levels of CCL17 were higher in mothers with AD than in those without AD (median 909.6 vs. 214.1 pg/mL, P<0.001). High umbilical cord serum levels of CCL17 were associated with infantile AD development even in 62 neonates born to mothers without AD (median 1514.4 vs. 740.6 pg/mL, P<0.001) and 38 neonates born to mothers with no allergies (median 1624.2 vs. 740.6 pg/mL, P<0.001). The summary estimates for umbilical cord serum CCL17 in the diagnosis of infantile AD were: sensitivity 85.7% (95% confidence interval: 72.8–98.7), specificity 73.8% (60.5–87.1), positive predictive value 68.6% (53.2–84.0) and negative predictive value 88.6% (78.0–99.1). Conclusion and Clinical Relevance These findings suggest that the umbilical cord blood CCL17 may be involved in the pathogenesis of infantile AD and in fetomaternal inheritance. Serum levels of CCL17 from umbilical cord blood may be a predictive marker for AD in infancy.]]></description><subject>Adult</subject><subject>Age of Onset</subject><subject>Allergic diseases</subject><subject>Atopic dermatitis</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>CCL17</subject><subject>CCL17 protein</subject><subject>Chemokine CCL17 - blood</subject><subject>chemokine TARC</subject><subject>Child, Preschool</subject><subject>Confidence intervals</subject><subject>CXCL10 protein</subject><subject>Dermatitis, Atopic - blood</subject><subject>Dermatitis, Atopic - congenital</subject><subject>Female</subject><subject>Fetal Blood - chemistry</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>gamma -Interferon</subject><subject>Heredity</subject><subject>Histocompatibility antigen HLA</subject><subject>Humans</subject><subject>Hypersensitivity</subject><subject>Immunoglobulin E</subject><subject>Immunopathology</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>IP-10 protein</subject><subject>Leukocytes (eosinophilic)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neonates</subject><subject>Pathogenesis</subject><subject>Predictive Value of Tests</subject><subject>Pregnancy</subject><subject>Prognosis</subject><subject>Reproducibility of Results</subject><subject>Serum levels</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>Stem cells</subject><subject>TARC</subject><subject>Umbilical cord</subject><subject>umbilical cord blood</subject><subject>Vagina</subject><issn>0954-7894</issn><issn>1365-2222</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2P0zAQhi0EYrsLfwFZQohTunYcJ_aBQxXKgqgALYv2aDnOGFzytXbCtv8eh5YicYGRJY_Gz-sZ-0UIU7KkMS63S8pynqQxlimJVcJyli13D9DidPAQLYjkWVIImZ2h8xC2hBDGpXiMzlJKeMaFWKCv6wZ-6BFqPLWVa5zRDTa9r3EAP7X4ZnVdXpblhhY4ctAEPHionRnx-A1wPZf6oYVuxL3FeuwHZ2LVt3p0owvYdXFZ3Zn9E_TI6ibA0-N-gb68Wd-Ub5PNx6t35WqTGJ6nWVIxSwtJUgmphbzKGctsLrjlBdO1tlUFqbac6phQLUVuKIgKWG1ETQnlKbtALw_3Dr6_myCMqnXBQNPoDvopKJGnhaAFE_8ms_hblEkZyed_kdt-8l18hootJSeRopESB8r4PgQPVg3etdrvFSVqdk1t1WyOms1Rs2vql2tqF6XPjg2mqoX6JPxtUwReHAEdokPWxy914Q_HCha9nWd4deDuXQP7_x5AlevVnEV9ctC7MMLupNf-u8oLVnB1--FK3b6-fv9ZfsoUYz8B03LAyQ</recordid><startdate>201102</startdate><enddate>201102</enddate><creator>Miyahara, H.</creator><creator>Okazaki, N.</creator><creator>Nagakura, T.</creator><creator>Korematsu, S.</creator><creator>Izumi, T.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201102</creationdate><title>Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy</title><author>Miyahara, H. ; Okazaki, N. ; Nagakura, T. ; Korematsu, S. ; Izumi, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5624-b3f179029e2fe6b6334f685f573adafbbe2af51abbe1a986c1e8be3dc8d101523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Allergic diseases</topic><topic>Atopic dermatitis</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>CCL17</topic><topic>CCL17 protein</topic><topic>Chemokine CCL17 - blood</topic><topic>chemokine TARC</topic><topic>Child, Preschool</topic><topic>Confidence intervals</topic><topic>CXCL10 protein</topic><topic>Dermatitis, Atopic - blood</topic><topic>Dermatitis, Atopic - congenital</topic><topic>Female</topic><topic>Fetal Blood - chemistry</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>gamma -Interferon</topic><topic>Heredity</topic><topic>Histocompatibility antigen HLA</topic><topic>Humans</topic><topic>Hypersensitivity</topic><topic>Immunoglobulin E</topic><topic>Immunopathology</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>IP-10 protein</topic><topic>Leukocytes (eosinophilic)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neonates</topic><topic>Pathogenesis</topic><topic>Predictive Value of Tests</topic><topic>Pregnancy</topic><topic>Prognosis</topic><topic>Reproducibility of Results</topic><topic>Serum levels</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>Stem cells</topic><topic>TARC</topic><topic>Umbilical cord</topic><topic>umbilical cord blood</topic><topic>Vagina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyahara, H.</creatorcontrib><creatorcontrib>Okazaki, N.</creatorcontrib><creatorcontrib>Nagakura, T.</creatorcontrib><creatorcontrib>Korematsu, S.</creatorcontrib><creatorcontrib>Izumi, T.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyahara, H.</au><au>Okazaki, N.</au><au>Nagakura, T.</au><au>Korematsu, S.</au><au>Izumi, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy</atitle><jtitle>Clinical and experimental allergy</jtitle><addtitle>Clin Exp Allergy</addtitle><date>2011-02</date><risdate>2011</risdate><volume>41</volume><issue>2</issue><spage>186</spage><epage>191</epage><pages>186-191</pages><issn>0954-7894</issn><eissn>1365-2222</eissn><abstract><![CDATA[Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191. Summary Background Thymus‐and‐activation‐regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical cord blood CCL17 to atopic dermatitis (AD) development have not yet been examined. Objective Seventy paired full‐term and normal vaginal delivery newborns and their mothers were enrolled in this study. Methods To elucidate the pathogenesis and fetomaternal inheritance of AD in infancy, CCL17, IFN‐γ‐inducible protein 10 kDa (IP‐10; CXCL10), soluble HLA‐G (sHLA‐G), IgE and eosinophil counts were examined using sera from 70 paired umbilical cord and maternal blood samples. Results Serum CCL17 (rs=0.340, P<0.001) and sHLA‐G (rs=0.600, P<0.001) levels showed high correlations between umbilical cord and maternal blood. Umbilical cord serum levels of CCL17 from neonates destined to develop AD in infancy were higher than in those from neonates who showed no signs of AD during infancy (median 1586.9 vs. 819.6 pg/mL, P<0.001). Serum levels of CCL17 were higher in mothers with AD than in those without AD (median 909.6 vs. 214.1 pg/mL, P<0.001). High umbilical cord serum levels of CCL17 were associated with infantile AD development even in 62 neonates born to mothers without AD (median 1514.4 vs. 740.6 pg/mL, P<0.001) and 38 neonates born to mothers with no allergies (median 1624.2 vs. 740.6 pg/mL, P<0.001). The summary estimates for umbilical cord serum CCL17 in the diagnosis of infantile AD were: sensitivity 85.7% (95% confidence interval: 72.8–98.7), specificity 73.8% (60.5–87.1), positive predictive value 68.6% (53.2–84.0) and negative predictive value 88.6% (78.0–99.1). Conclusion and Clinical Relevance These findings suggest that the umbilical cord blood CCL17 may be involved in the pathogenesis of infantile AD and in fetomaternal inheritance. Serum levels of CCL17 from umbilical cord blood may be a predictive marker for AD in infancy.]]></abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21054588</pmid><doi>10.1111/j.1365-2222.2010.03634.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0954-7894
ispartof Clinical and experimental allergy, 2011-02, Vol.41 (2), p.186-191
issn 0954-7894
1365-2222
language eng
recordid cdi_proquest_miscellaneous_862781738
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Age of Onset
Allergic diseases
Atopic dermatitis
Biological and medical sciences
Biomarkers - blood
Case-Control Studies
CCL17
CCL17 protein
Chemokine CCL17 - blood
chemokine TARC
Child, Preschool
Confidence intervals
CXCL10 protein
Dermatitis, Atopic - blood
Dermatitis, Atopic - congenital
Female
Fetal Blood - chemistry
Fundamental and applied biological sciences. Psychology
Fundamental immunology
gamma -Interferon
Heredity
Histocompatibility antigen HLA
Humans
Hypersensitivity
Immunoglobulin E
Immunopathology
Infant
Infant, Newborn
IP-10 protein
Leukocytes (eosinophilic)
Male
Medical sciences
Neonates
Pathogenesis
Predictive Value of Tests
Pregnancy
Prognosis
Reproducibility of Results
Serum levels
Skin allergic diseases. Stinging insect allergies
Stem cells
TARC
Umbilical cord
umbilical cord blood
Vagina
title Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A32%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20umbilical%20cord%20serum%20TARC/CCL17%20levels%20predict%20the%20development%20of%20atopic%20dermatitis%20in%20infancy&rft.jtitle=Clinical%20and%20experimental%20allergy&rft.au=Miyahara,%20H.&rft.date=2011-02&rft.volume=41&rft.issue=2&rft.spage=186&rft.epage=191&rft.pages=186-191&rft.issn=0954-7894&rft.eissn=1365-2222&rft_id=info:doi/10.1111/j.1365-2222.2010.03634.x&rft_dat=%3Cproquest_cross%3E862781738%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1529501391&rft_id=info:pmid/21054588&rfr_iscdi=true